Current Cancer Drug Targets

Papers
(The median citation count of Current Cancer Drug Targets is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors38
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer27
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy26
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance24
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy22
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy22
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks21
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors20
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin19
Exosome as a Natural Gene Delivery Vector for Cancer Treatment18
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer17
Antibody-drug Conjugate Targets, Drugs, and Linkers16
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy16
Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process15
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent15
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention14
The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review13
Resistance of Lenvatinib in Hepatocellular Carcinoma13
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)12
Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting12
Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma12
Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?11
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial11
A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer11
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms11
MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX111
Current Treatment and Future Trends of Immunotherapy in Breast Cancer10
Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis10
Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling9
Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma9
Modulation of Matrix Metalloproteinases by Plant-derived Products9
mRNA Vaccine - A New Cancer Treatment Strategy9
Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs- TRAIL) Increases Antitumor Efficacy of Their Secretome9
Cross Talk between COVID-19 and Breast Cancer9
β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer9
The Roles of Alternative Splicing in Tumor-immune Cell Interactions9
Pharmacological Targeting of Ferroptosis in Cancer Treatment9
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma9
Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer8
Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways8
ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma8
Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells8
Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy8
The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular Carcinoma8
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study8
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators8
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC7
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues7
Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism7
LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy7
Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling7
Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer7
Metastatic Breast Cancer, Organotropism and Therapeutics: A Review7
New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles7
Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis7
Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer7
Autophagy in Cancer Cell Transformation: A Potential Novel Therapeutic Strategy7
The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells7
ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments6
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked6
Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities6
PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors6
Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer6
Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism6
Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation6
Cholangiocarcinoma Therapeutics: An Update6
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells6
Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients6
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types6
Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice6
Mesenchymal Epithelial Transition (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer Immunotherapy6
Effects of Iron Chelation in Osteosarcoma6
Role of Exosomes in Breast Cancer Management: Evidence-Based Review6
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling6
PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance6
NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma5
Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells5
miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance5
Assessing Long Non-coding RNAs in Tobacco-associated Oral Cancer5
HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer5
Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells5
MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer5
Modulation of ATP8B1 Gene Expression in Colorectal Cancer Cells Suggest its Role as a Tumor Suppressor5
State-of-the-Art: Exosomes in Colorectal Cancer5
Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin5
Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study5
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression5
Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy5
Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-based Drugs?5
Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B15
Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers5
Dextran Sulfate Inhibits Angiogenesis and Invasion of Gastric Cancer by Interfering with M2-type Macrophages Polarization5
Inorganic Phosphate (Pi) in the Breast Cancer Microenvironment: Production, Transport and Signal Transduction as Potential Targets for Anticancer Strategies4
Probiotics as a Therapeutic Approach in Colorectal Cancer4
Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma4
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications4
Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric Cancer4
The Long Non-coding RNA Cytoskeleton Regulator (CYTOR) Sponges microRNA- 206 (miR-206) to Promote Proliferation and Invasion of HP75 Cells4
Advancement and Strategies for the Development of Peptide-drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence against Cancer Management4
The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis4
VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells4
Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy4
Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets4
Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics4
Drug-Induced Peripheral Neuropathy: Diagnosis and Management4
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression4
TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways4
Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8+ T Cells4
BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway4
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway4
Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells4
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediated AKT /JNK and p53 Signaling Pathway4
The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future4
Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib4
Protein Arginine Methyltransferases 5 (PRMT5) affect Multiple Stages of Autophagy and Modulate Autophagy-related Genes in Controlling Breast Cancer Tumorigenesis4
Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma4
HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness4
Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics4
The Current and Evolving Role of Immunotherapy in Metastatic Colorectal Cancer3
Mitochondrial Calcium Uniporter (MCU) that Modulates Mitochondrial Calcium Uptake and Facilitates Endometrial Cancer Progression through Interaction with VDAC13
Potential Therapeutic Strategies for Targeting Y-Box-Binding Protein 1 in Cancers3
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies3
Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity3
Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy3
An Overview of Promising Biomarkers in Cancer Screening and Detection3
Lycopene as a Potential Bioactive Compound: Chemistry, Extraction, and Anticancer Prospective3
Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma3
cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer3
Saikosaponin B4 Suppression Cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon Cancer3
Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling3
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer3
Present and Future Prospects of the Anti-cancer Activities of Saikosaponins3
Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids3
The Interactions among Hypertension, Cancer, and COVID-19: Perspective with Regard to Ca2+/cAMP Signalling3
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers3
Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis3
Study on Cellular Localization of Bin Toxin and its Apoptosis-inducing Effect on Human Nasopharyngeal Carcinoma Cells3
The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer3
Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR13
Regulation of Breast Cancer Progression by Noncoding RNAs3
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase3
Dihydrotanshinone I Inhibits Pancreatic Cancer Progression via Hedgehog/ Gli Signal Pathway3
Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target3
Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway3
MALAT1 as a Versatile Regulator of Cancer: Overview of the Updates from Predatory Role as Competitive Endogenous RNA to Mechanistic Insights3
Synthesis and Preliminary Evaluations of [18F]fluorinated Pyridine-2- carboxamide Derivatives for Targeting PD-L1 in Cancer3
An Overview of CDK Enzyme Inhibitors in Cancer Therapy3
Aminopeptidases in Cancer, Biology and Prospects for Pharmacological Intervention3
Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma3
Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies3
The Therapeutic Potential of Targeting Autophagy in the Treatment of Cancer3
PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells2
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors2
Therapeutic Potential of Clostridium novyi-NT in Cancer: Current Knowledge and Future Perspectives2
Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer2
Combination of Cefotaxime and Cisplatin Specifically and Selectively Enhances Anticancer Efficacy in Nasopharyngeal Carcinoma2
Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells2
Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction2
FA-HA-Amygdalin@Fe2O3 and/or γ-Rays Affecting SIRT1 Regulation of YAP/TAZ-p53 Signaling and Modulates Tumorigenicity of MDA-MB231 or MCF-7 Cancer Cells2
Combined Transarterial Chemoembolization with Microwave Ablation versus Microwave Alone for Treatment of Medium Sized Hepatocellular Carcinoma2
Insight into the Basic Mechanisms and Various Modulation Strategies Involved in Cancer Drug Resistance2
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice2
Geiparvarin Inhibits the Progression of Osteosarcoma by Down-regulating COX2 Expression2
CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human Glioblastoma2
Characteristic Hallmarks of Aging and the Impact on Carcinogenesis2
Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic Cancer using Nanotechnology2
UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer2
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma2
A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer2
Pathological Implications of Mucin Signaling in Metastasis2
Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy2
Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription2
Anti-Obesity Medications in Cancer Therapy: A Comprehensive Insight2
Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway2
GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study2
SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer2
Targeted Biological Effect of An Affitoxin Composed of an HPV16E7 Affibody Fused with Granzyme B (ZHPV16E7-GrB) Against Cervical Cancer In vitro and In vivo2
Ligand-mediated Targeted Drug Delivery Approaches against Hepatocellular Carcinoma2
LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells2
Salivary Protein Biomarkers for Diagnosis of Oral Squamous Cell Carcinoma2
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity2
Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development2
Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis2
Treatment Advances in Lung Cancer with Leptomeningeal Metastasis2
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis2
Application of Thermoresponsive Smart Polymers based in situ Gel as a Novel Carrier for Tumor Targeting2
Cuproptosis Related Gene DLD Associated with Poor Prognosis and Malignant Biological Characteristics in Lung Adenocarcinoma2
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer2
Targeting NUPR1 for Cancer Treatment: A Risky Endeavor2
AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway2
A Pan-cancer Analysis to Determine the Prognostic Analysis and Immune Infiltration of HSPA52
Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin2
Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer1
A Saffron-based Polyherbal Formulation DuK Prevents Hepatocellular Carcinoma in Male Wistar Rats1
Promotion of Cervical Cancer Cell Proliferation by miR-130b Expression Level Changes and Inhibition of its Apoptosis by Targeting CDKN1A Gene1
Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives1
The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experien1
The Epigenetic Factors that Drive Cancer Drug Resistance1
EZH2-regulated PARP-1 Expression is a Likely Mechanism for the Chemoresistance of Gliomas to Temozolomide1
Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner1
COL10A1 as a Prognostic Biomarker in Association with Immune Infiltration in Prostate Cancer1
DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma1
Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer1
The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer1
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma1
Naringenin-induced Oral Cancer Cell Apoptosis Via ROS-mediated Bid and Bcl-xl Signaling Pathway1
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance1
Modifications of Ribonucleases in Order to Enhance Cytotoxicity in Anticancer Therapy1
Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating EZH2 in Gastric Carcinoma1
The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis: The Postchemotherapy Open RPLND Experience1
ND-16: A Novel Compound for Inhibiting the Growth of Cutaneous T Cell Lymphoma by Targeting JAK21
Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics1
The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma Therapeutic Agent1
Impact of GSTT1 and GSTM1 Polymorphisms in the Susceptibility to Philadelphia Negative Chronic Myeloid Leukaemia1
Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma: Disrupting the Tumor-stromal Cross-talk, Next Hope on the Horizon?1
Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer1
IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma1
Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered Method of Immunotherapy for Cancer1
Research Progress of Neural Invasion in Pancreatic Cancer1
Network pharmacology and in vitro experiments reveal that Noscapine induces ROS-mediated apoptosis and cell cycle arrest via PI3K/Akt/FoxO3a signaling pathway in human bladder cancer cells1
High Level of Adropin Promotes the Progression of Pancreatic Ductal Adenocarcinoma1
Establishment and Validation of a Blood Test-based Nomogram to Diagnose Patients with AFP-negative HCC1
Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehyd1
The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy1
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells1
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors1
UBR5 Significantly Correlates with Osteosarcomas Prognosis and Immune Exhaustion Characteristic in the Tumor Microenvironment1
Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective1
Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian Patients1
IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration1
The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review1
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study1
BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular Carcinoma1
The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy1
Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis1
Withanone as an Emerging Anticancer Agent and Understanding Its Molecular Mechanisms: Experimental and Computational Evidence1
Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer1
Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD501
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer1
Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors1
Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer1
Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling1
0.025365114212036